Grail, Inc. (NASDAQ:GRAL - Get Free Report)'s share price hit a new 52-week high on Thursday . The stock traded as high as $34.44 and last traded at $34.39, with a volume of 1457859 shares trading hands. The stock had previously closed at $28.28.
Analyst Upgrades and Downgrades
GRAL has been the topic of a number of recent research reports. Morgan Stanley started coverage on Grail in a report on Wednesday, November 27th. They set an "equal weight" rating and a $16.00 price objective on the stock. Guggenheim assumed coverage on Grail in a research report on Thursday, October 17th. They issued a "neutral" rating on the stock. Finally, Wolfe Research started coverage on shares of Grail in a research note on Friday, November 15th. They issued a "peer perform" rating on the stock.
Read Our Latest Stock Analysis on GRAL
Grail Stock Performance
The company's fifty day moving average price is $21.72 and its two-hundred day moving average price is $17.17.
Grail (NASDAQ:GRAL - Get Free Report) last issued its quarterly earnings results on Tuesday, November 12th. The company reported ($3.94) earnings per share (EPS) for the quarter. The company had revenue of $28.65 million for the quarter. Equities research analysts forecast that Grail, Inc. will post -65.16 EPS for the current year.
Insider Activity
In other news, CFO Aaron Freidin sold 30,452 shares of the firm's stock in a transaction on Monday, November 18th. The stock was sold at an average price of $14.02, for a total value of $426,937.04. Following the transaction, the chief financial officer now directly owns 268,277 shares in the company, valued at $3,761,243.54. This trade represents a 10.19 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.
Institutional Trading of Grail
Institutional investors and hedge funds have recently modified their holdings of the stock. Crcm LP acquired a new position in Grail during the fourth quarter valued at approximately $65,061,000. Bank of New York Mellon Corp acquired a new position in shares of Grail in the 4th quarter valued at approximately $6,262,000. TCW Group Inc. bought a new stake in shares of Grail during the fourth quarter worth $5,095,000. abrdn plc bought a new stake in shares of Grail in the fourth quarter valued at about $3,768,000. Finally, Douglas Lane & Associates LLC bought a new stake in shares of Grail in the fourth quarter worth $3,034,000.
Grail Company Profile
(
Get Free Report)
GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.
See Also
Before you consider Grail, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Grail wasn't on the list.
While Grail currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
